TOP HEADLINES

Featured Story

Study: Inhalable encapsulated antibiotic from Aradigm kills 99% of infections

A team of scientists from Oregon State University and Aradigm, a small pulmonary device company out of California, touted successful in vitro results for its inhaled, encapsulated ciproflaxacin treatment for infections associated with the lungs.

Magnetic anesthesia: Delivering nerve blocks locally with a targeted approach

In an effort to localize the effects of anesthesia, researchers have turned to magnetic nanoparticles to target the delivery of ropivacaine in a proof-of-concept animal study.

Alliqua pulls in $20M to support hydrogel wound care biz

Pennsylvania wound-care specialist Alliqua pulled in $15 million from a private funding round and another $5.3 million from the exercise of warrants, giving the company a $20.3 million windfall overall.

Study shows nanoparticles can lose their uniform shape, size under lab conditions

As drug delivery becomes more and more dependent on nanotechnology for treatments such as chemotherapy, it's important that scientists in the field understand the implications of the tiny vehicles and what factors might play a part, for good or bad, in their delivery potential.

Nanoballoons 'pop' open to deliver cancer drugs when hit with a red laser

Researchers at the University at Buffalo have put the "pop" into drug delivery by releasing compounds from liposomes called nanoballoons that break open upon being hit with a laser.

MORE NEWS